LEMCOA: Longitudinal Study to Determine the Effectiveness of the Mobility Checkup for Older Adults

Sponsor
College of St. Scholastica, Inc. (Other)
Overall Status
Recruiting
CT.gov ID
NCT05745402
Collaborator
(none)
30
1
1
16.4
1.8

Study Details

Study Description

Brief Summary

The investigators are developing a new, preventative physical therapy model of care for older adults called Mobility Checkup (MC). Proposed as an annual visit, the MC includes measurement of physical performance and education regarding the importance of maintaining mobility for overall health. The purpose of this study is to determine the feasibility of and begin data collection for, a longitudinal study of the effectiveness of the Mobility Checkup with a small cohort. This activity will evaluate the feasibility of recruitment and implementation of this longitudinal effectiveness study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mobility Checkup for older adults
N/A

Detailed Description

Healthy aging is defined as "the process of developing and maintaining the functional ability that enables well-being in older age" and includes mobility. Mobility disability (i.e., the inability to walk 400 meters and climb a flight of stairs without assistance) is the most prevalent form of disability for older adults in the United States. Unlike blood pressure or body mass index, physical performance measures such as walking speed help identify and predict preclinical mobility disability, but are rarely used in routine medical care. This is a missed opportunity, particularly for older adults, who may experience a subtle decline in physical performance that leads to mobility disability.

The position of the American Physical Therapy Association is that all people should have an annual physical therapy visit to optimize movement and promote health, wellness, and fitness; and slow the progression of impairments of body functions and structures, activity limitations, and participation restrictions.

Recommendations support preventive care for maintaining mobility. However, a model of care specific to preventing mobility disability in older adults is not common practice. Evidence suggests routine screening can predict mobility disability in older adults and that activity-based interventions prevent it.

The is year 1 of a longitudinal study that will determine the feasibility of an effectiveness study of a Mobility Checkup, an annual preventive visit within a model of physical therapy care. The Mobility Checkup prioratizes educating older adults on the value of physical performance as an indicator of health and aims to maintain mobility and reduce mobility disability among participants. Ultimately, this new model of care could result in a cost-effective tool to establish baseline physical performance and identify and prevent preclinical and mobility disabilities in older adults.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Longitudinal Study of the Effectiveness of the Mobility Checkup for Older Adults: Feasibility in the 'Year 1' Cohort
Actual Study Start Date :
Feb 16, 2023
Anticipated Primary Completion Date :
May 31, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mobility Checkup Intervention

45-minute Mobility checkup that includes 5 physical performance measures and education based on outcomes compared to age and gender normative values.

Behavioral: Mobility Checkup for older adults
The Mobility Checkup (MC) for older adults is a 45-minute preventative physical therapy visit designed to maintain mobility during aging. It has two parts, measurement (25 minutes) and education (20 minutes). The 5 standardized measures of physical performance in the MC are Walking speed, single leg stance time (balance), Five rep sit to stand (muscular endurance, transitions), 6-meter walk test (general endurance), and Timed up from floor test (transitions). Participants are provided education structured into 4 elements. 1. They are told their performance scores 2. They are shown how their performance scores on each of the measures compare to age and sex-referenced normative values 3. They are provided information about what their performance predicts about their health 4. They are referred to an appropriate provider if there was a health or safety concern during their MC or they are educated to follow the recommendations for physical activity that are recommended by the CDC.

Outcome Measures

Primary Outcome Measures

  1. LASA Physical Activity Questionnaire (LAPAQ) [one year]

    Questionnaire designed to measure the amount of physical activity a person completed over the last two weeks.

Secondary Outcome Measures

  1. The 6-minute walk test [one year]

    In the 6-minute walk test the distance in meters a person can walk in 6 minutes is measured as evidence of their endurance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 55 years of age or older

  • Walk independently with or without an assistive device

Exclusion Criteria:
  • Experiencing short-term condition affecting their mobility

  • Cardiac procedure or myocardial infarction (heart attack) in the last 6 months

  • Has a guardian who is responsible for their healthcare decisions

Contacts and Locations

Locations

Site City State Country Postal Code
1 College of St. Scholastica-Health Science Center Duluth Minnesota United States 55812

Sponsors and Collaborators

  • College of St. Scholastica, Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alexandra Borstad, Associate Professor, College of St. Scholastica, Inc.
ClinicalTrials.gov Identifier:
NCT05745402
Other Study ID Numbers:
  • 1234
First Posted:
Feb 27, 2023
Last Update Posted:
Mar 1, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 1, 2023